Related Articles
PI3K p110α inhibition sensitizes cervical cancer cells with aberrant PI3K signaling activation to PARP inhibitor BMN673
PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells
The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition
Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report.
HELQ reverses the malignant phenotype of osteosarcoma cells via CHK1-RAD51 signaling pathway